|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 147.25 INR | -0.61% |
|
-11.21% | +79.03% |
| 05-22 | IOL Chemicals and Pharmaceuticals Limited, Q4 2026 Earnings Call, May 22, 2026 | |
| 05-20 | IOL Chemicals and Pharmaceuticals March-quarter consol profit 531.6 million rupees | RE |
| Market Cap | 43.22B 446M 393M 365M 335M 629M 640M 4.36B 1.7B 21.08B 1.68B 1.64B 73.14B | P/E 2026 |
15.5x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 43.22B 446M 393M 365M 335M 629M 640M 4.36B 1.7B 21.08B 1.68B 1.64B 73.14B | EV / Sales 2026 |
0.92x | EV / Sales 2027 * | 1.63x |
| Free-Float |
33.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IOL Chemicals and Pharmaceuticals Limited
| 1 day | -0.61% | ||
| 1 week | -11.21% | ||
| Current month | +1.41% | ||
| 1 month | +12.71% | ||
| 3 months | +56.57% | ||
| 6 months | +104.49% | ||
| Current year | +79.03% |
| 1 week | 145.5 | 164.75 | |
| 1 month | 130.35 | 179.65 | |
| Current year | 67.14 | 179.65 | |
| 1 year | 67.14 | 179.65 | |
| 3 years | 57.51 | 179.65 | |
| 5 years | 54.44 | 179.65 | |
| 10 years | 8.4 | 179.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | 34 | - |
Pardeep Khanna
DFI | Director of Finance/CFO | - | - |
Abhay Raj Singh
CMP | Compliance Officer | - | 2019-11-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Varinder Gupta
CHM | Chairman | 63 | 2007-08-31 |
Vikas Gupta
BRD | Director/Board Member | 34 | 2015-05-28 |
| Chairman | 73 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.61% | -11.21% | +52.70% | +98.00% | 451M | ||
| +1.51% | +1.08% | +47.93% | +157.29% | 1,037B | ||
| +0.93% | +3.35% | +52.77% | +51.01% | 615B | ||
| +1.05% | +0.79% | +34.55% | +79.07% | 448B | ||
| +5.14% | +5.40% | +33.75% | +27.79% | 326B | ||
| +1.85% | +3.57% | +37.09% | +40.59% | 293B | ||
| -0.11% | +0.48% | +18.87% | +17.70% | 264B | ||
| +0.25% | -4.62% | -27.66% | -41.76% | 216B | ||
| +0.36% | -1.10% | +18.84% | +56.10% | 198B | ||
| -0.44% | -4.72% | +14.35% | +67.22% | 162B | ||
| Average | +0.97% | -0.06% | +28.32% | +55.30% | 355.79B | |
| Weighted average by Cap. | +1.35% | +1.47% | +35.01% | +75.47% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 23.04B 238M 209M 194M 179M 335M 341M 2.32B 906M 11.24B 893M 874M 38.98B | 26.48B 273M 241M 223M 206M 385M 392M 2.67B 1.04B 12.92B 1.03B 1B 44.82B |
| Net income | 1.3B 13.38M 11.77M 10.93M 10.06M 18.86M 19.2M 131M 51M 632M 50.24M 49.15M 2.19B | - |
| Net Debt | - | - |
Employees
2,891
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | ₹147.25 | -0.61% | 134,273 |
| 26-07-22 | ₹148.15 | -1.89% | 102,905 |
| 26-07-21 | ₹151.00 | -2.83% | 131,783 |
| 26-07-20 | ₹155.40 | +4.44% | 389,466 |
| 26-07-17 | ₹148.80 | -9.32% | 438,670 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
147.25INR
Average target price
150.00INR
Spread / Average Target
+1.87%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IOLCP Stock
Select your edition
All financial news and data tailored to specific country editions

















